1. Home/
  2. Compounds/
  3. doxorubicin:navitoclax (2:1 mol/mol)

doxorubicin:navitoclax (2:1 mol/mol)

Synonyms

SourcesNames Used
CTRPv2doxorubicin:navitoclax (2:1 mol/mol)
PharmacoGx doxorubicin:navitoclax (2:1 mol/mol)

FDA Approval Status

Not Approved
Dataset Select
Download Data as CSV

Top molecular features associated with response to doxorubicin:navitoclax (2:1 mol/mol)


Feature TypeStandardized
Nominal ANOVA
mRNA SP4 CTRPv2 pan-cancer AAC 0.22 2e-11
mRNA HDAC2 CTRPv2 pan-cancer AAC 0.22 2e-11
mRNA BEND3 CTRPv2 pan-cancer AAC 0.23 3e-11
mRNA RTFDC1 CTRPv2 pan-cancer AAC -0.23 3e-11
mRNA SFPQ CTRPv2 pan-cancer AAC 0.23 4e-11
mRNA IPO9 CTRPv2 pan-cancer AAC 0.22 6e-11
mRNA PHIP CTRPv2 pan-cancer AAC 0.22 6e-11
mRNA ICA1L CTRPv2 pan-cancer AAC 0.21 9e-11
mRNA YPEL1 CTRPv2 pan-cancer AAC 0.22 1e-10
mRNA IRAK1BP1 CTRPv2 pan-cancer AAC 0.22 1e-10
Download CSV